JIM - Journal of Internal Medicine
@JInternMed
Followers
2K
Following
877
Media
862
Statuses
2K
A peer-reviewed journal in the field of internal medicine. Impact Factor 9.2. ✉️ [email protected]
Sweden
Joined November 2012
News Release! New article! Can therapies against cellular aging help treat metabolic diseases?, via @EurekAlert!
eurekalert.org
A growing body of evidence implicates cellular senescence—when cells age and permanently stop dividing—as an important contributor to metabolic dysfunction that can lead to obesity, type 2 diabetes,...
0
0
0
New review to read! #Senotherapeutics for #metabolic disease and diabetic complications. ➡️ From the Symposium: Role of Cell Senescence and Senolytic Therapy for Metabolic Disorders. 🔗 https://t.co/IUpZT4BRW9
0
0
0
Welcome to read the Editor´s Choice in November! ➡️ Sixty years of experience with hereditary transthyretin #amyloidosis ➡️Insights from the Swedish transthyretin amyloidosis registry 🔗 https://t.co/jO0c739Yh3 👉 Also, read the November issue: https://t.co/sZRLhsMphG
#ATTRv
0
0
0
New review to read! #Reproductive toxicity of micro- and #nanoplastics: Insights from experimental and human studies. 👉From the 19th Key Symposium: Planetary Health—connect the dots. What saves the planet saves our health. 🚨🌿 #PlanetaryHealth25 🔗 https://t.co/jXbd0bM2CB
0
0
0
The November issue is now online! 👉 Read our latest articles! 🔗 https://t.co/sZRLhsMphG
#kidneys #CKD #neuroendocrinology #addiction #antibiotics #arteritis #PMR #retroperitoneal #fibrosis #anticoagulation #gastrointestinal #bleeding #atrialfibrillation #HDL #coronary
0
1
1
Focus Issue on global health: Infection and obesity! 🚨 Causes, health risks, key metabolic pathways, latest treatments, and prevention strategies for diabetes, cardiovascular disease, and related conditions. 👉Read it now! https://t.co/WiAq1nUhKB
#GlobalHealth #obesity
0
0
0
New article from @UTexasPharmacy! Trends, timing, and predictors of #alcohol use disorder treatment among US adult #cancer survivors. ➡️Interventions are warranted to enhance treatment initiation. ➡️To reduce alcohol-related harms. 🔗 https://t.co/6Pd62BdSHD
0
1
3
New article to read! 🚨💊 Statins linked to ↓ risk of #IBD: 👉In a Danish cohort of >650K adults eligible for #statin use for primary CV prevention- statin use was associated with a 16% lower risk of developing #IBD. 🔗 https://t.co/esnL5fBCKw
0
1
3
New article! Association of histologic and clinical activity with major adverse #cardiovascular events in patients with #inflammatory #bowel disease. ➡️ Improved disease control may reduce MACE risk in IBD. 🔗 https://t.co/JW0z9zkX12
#IBD #MACE #MedTwitter
0
0
2
New Perspective to read! Ignoring the planet: A critical blind spot for research on ageing. 🌿From the 19th Key Symposium: Planetary Health – connect the dots. What saves the planet saves our health. 🔗 https://t.co/f4vwuTJ4QF
#PlanetaryHealth25 #ageing #Longevity
0
0
0
New article to read! High #cholesterol absorption efficiency interferes with bile acid metabolism and cholesterol elimination from the body. ➡️Risk of atherosclerosis ➡️Can be prevented by dietary means combined with ezetimibe and statin treatment 🔗 https://t.co/YXtATV0nHJ
0
0
0
#LiverTransplantation and treatment with disease-modifying therapies significantly improve survival in patients with hereditary variant transthyretin amyloidosis, which can lead to cardiomyopathy (#ATTRCM) and polyneuropathy (#ATTRPN). @JInternMed Read:
rarediseaseadvisor.com
Liver transplant and disease-modifying therapy may improve survival in patients with ATTR-CM and ATTR-PN based on 60 years of Swedish data.
0
1
1
New Original Article to read! Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk 🔗 https://t.co/ewsb88Gij5
#IBD #PSC
#colorectalcancer #livertransplant
0
0
1
New Original Article! Systemic neutrophil activation and N-formyl methionine-formyl peptide receptor-1 signaling define inflammatory endotypes in rheumatoid arthritis-associated lung involvement 🔗 https://t.co/VWunFQMRKn
#FPR1 #rheumatoidarthritis #interstitiallungdisease
0
0
0
New review from researchers at #Karolinskainstitutet! Health inequalities in the Nordic countries: A comparative overview and update 🔗 https://t.co/P69bnqmFjm
#healthinequality #mortality
0
0
0
New article! CD71+ erythroid cell expansion in late-onset systemic lupus erythematosus. ➡️SLE mainly affects women of reproductive age ➡️Late-onset #SLE patients are generally indolent and have less severe manifestations ➡️Potential molecular markers 🔗 https://t.co/ZO1WCGXiZ3
0
0
0
Welcome to read the Editor´s Choice in October! ➡️Low-protein diet for chronic kidney disease ➡️Evidence, controversies, and practical guidelines 🔗 https://t.co/0nMcvYB3Dm 👉Also, read the October issue: https://t.co/oLXzT83jPI
#CKD #nutrition #MedTwitter
0
0
1
Tracking Type 2 Diabetes in Korea: Findings from a 20-Year Cohort study shows people can stay normoglycemic for decades, but once #prediabetes develops, progression to #diabetes is fast—no matter the type. 📎 https://t.co/0FhadSyHtc
0
2
3
Focus Issue on global health: Infection-related chronic conditions! 💡Long-term health effects 💡COVID-19, immune function, neurodegeneration, cancer risk, global disease management strategies 💡A global challenge Read it now 👉 https://t.co/Nu04b4Bee6
#GlobalHealth #COVID_19
0
0
0
The October issue is now online! Read our latest articles! 🔗 https://t.co/oLXzT83jPI
#ChronicPain #Oncology #AML #CKD #T2DM #ALS #Hypertension #Cardiology #MedTwitter
0
0
1